Cargando…

Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis

Mice with hepatocyte-specific deletion of autophagy-related 7 (Atg7(ΔHep) mice) develop hepatoma, suggesting that autophagy deficiency could be a factor in the initiation of tumorigenesis. We have shown that FGF21 is induced as a ‘mitokine’ when Atg7 is disrupted in insulin target tissues such as th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinyoung, Lee, Soyeon, Lee, Myung-Shik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936433/
https://www.ncbi.nlm.nih.gov/pubmed/35321438
http://dx.doi.org/10.3389/fonc.2022.832804
_version_ 1784672217433374720
author Kim, Jinyoung
Lee, Soyeon
Lee, Myung-Shik
author_facet Kim, Jinyoung
Lee, Soyeon
Lee, Myung-Shik
author_sort Kim, Jinyoung
collection PubMed
description Mice with hepatocyte-specific deletion of autophagy-related 7 (Atg7(ΔHep) mice) develop hepatoma, suggesting that autophagy deficiency could be a factor in the initiation of tumorigenesis. We have shown that FGF21 is induced as a ‘mitokine’ when Atg7 is disrupted in insulin target tissues such as the liver, which could affect systemic metabolism through endocrine activity. Since FGF21 or other endocrine FGF such as FGF19 can affect tumor growth, we hypothesized that FGF21 produced by Atg7-knockout (KO) hepatocytes may affect the behavior of Atg7-KO hepatoma in an autocrine manner. We, thus, crossed Atg7(ΔHep) mice with systemic Fgf21-KO (Fgf21(−/−)) mice to generate Atg7(ΔHep)Fgf21(−/−) mice. The number and size of hepatoma of Atg7(ΔHep) mice were significantly increased by additional Fgf21 KO. The proliferation of Atg7-KO hepatocyte was significantly increased by Fgf21 KO. pYAP1/YAP1 representing YAP1 degradation was significantly decreased in the liver of Atg7(ΔHep)Fgf21(−/−) mice compared to Atg7(ΔHep)Fgf21(+/+) mice. Consistently, expression of YAP1/TAZ downstream genes was significantly increased in the liver of Atg7(ΔHep)Fgf21(−/−) mice compared to Atg7(ΔHep)Fgf21(+/+) mice, which could explain the increased size of hepatoma in Atg7(ΔHep)Fgf21(−/−) mice. Accumulation of ROS and ROS-mediated DNA damage were increased in the liver of Atg7(ΔHep)Fgf21(+/+) mice, which was further aggravated by additional Fgf21 KO probably due to the absence of positive effect of FGF21 on mitochondrial function, explaining the increased number of hepatoma in Atg7(ΔHep)Fgf21(−/−) mice compared to Atg7(ΔHep)Fgf21(+/+) mice. These results show that FGF21 produced by autophagy-deficient hepatocytes could have autocrine or paracrine effects on the number and proliferation of autophagy-deficient hepatoma, suggesting that hormones or factors released from autophagy-deficient tumors can influence the behavior or prognosis of the tumor in addition to the effects on host metabolism.
format Online
Article
Text
id pubmed-8936433
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89364332022-03-22 Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis Kim, Jinyoung Lee, Soyeon Lee, Myung-Shik Front Oncol Oncology Mice with hepatocyte-specific deletion of autophagy-related 7 (Atg7(ΔHep) mice) develop hepatoma, suggesting that autophagy deficiency could be a factor in the initiation of tumorigenesis. We have shown that FGF21 is induced as a ‘mitokine’ when Atg7 is disrupted in insulin target tissues such as the liver, which could affect systemic metabolism through endocrine activity. Since FGF21 or other endocrine FGF such as FGF19 can affect tumor growth, we hypothesized that FGF21 produced by Atg7-knockout (KO) hepatocytes may affect the behavior of Atg7-KO hepatoma in an autocrine manner. We, thus, crossed Atg7(ΔHep) mice with systemic Fgf21-KO (Fgf21(−/−)) mice to generate Atg7(ΔHep)Fgf21(−/−) mice. The number and size of hepatoma of Atg7(ΔHep) mice were significantly increased by additional Fgf21 KO. The proliferation of Atg7-KO hepatocyte was significantly increased by Fgf21 KO. pYAP1/YAP1 representing YAP1 degradation was significantly decreased in the liver of Atg7(ΔHep)Fgf21(−/−) mice compared to Atg7(ΔHep)Fgf21(+/+) mice. Consistently, expression of YAP1/TAZ downstream genes was significantly increased in the liver of Atg7(ΔHep)Fgf21(−/−) mice compared to Atg7(ΔHep)Fgf21(+/+) mice, which could explain the increased size of hepatoma in Atg7(ΔHep)Fgf21(−/−) mice. Accumulation of ROS and ROS-mediated DNA damage were increased in the liver of Atg7(ΔHep)Fgf21(+/+) mice, which was further aggravated by additional Fgf21 KO probably due to the absence of positive effect of FGF21 on mitochondrial function, explaining the increased number of hepatoma in Atg7(ΔHep)Fgf21(−/−) mice compared to Atg7(ΔHep)Fgf21(+/+) mice. These results show that FGF21 produced by autophagy-deficient hepatocytes could have autocrine or paracrine effects on the number and proliferation of autophagy-deficient hepatoma, suggesting that hormones or factors released from autophagy-deficient tumors can influence the behavior or prognosis of the tumor in addition to the effects on host metabolism. Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8936433/ /pubmed/35321438 http://dx.doi.org/10.3389/fonc.2022.832804 Text en Copyright © 2022 Kim, Lee and Lee https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kim, Jinyoung
Lee, Soyeon
Lee, Myung-Shik
Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
title Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
title_full Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
title_fullStr Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
title_full_unstemmed Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
title_short Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
title_sort suppressive effect of autocrine fgf21 on autophagy-deficient hepatic tumorigenesis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936433/
https://www.ncbi.nlm.nih.gov/pubmed/35321438
http://dx.doi.org/10.3389/fonc.2022.832804
work_keys_str_mv AT kimjinyoung suppressiveeffectofautocrinefgf21onautophagydeficienthepatictumorigenesis
AT leesoyeon suppressiveeffectofautocrinefgf21onautophagydeficienthepatictumorigenesis
AT leemyungshik suppressiveeffectofautocrinefgf21onautophagydeficienthepatictumorigenesis